Evidence map›Paper›PMID 24391778›Full record

ArticlePloS one2013

Mannan-binding lectin inhibits Candida albicans-induced cellular responses in PMA-activated THP-1 cells through Toll-like receptor 2 and Toll-like receptor 4.

Mingyong Wang, Fanping Wang, Jianbin Yang, Dongfang Zhao, Hongpo Wang, Feng Shao, Wenjun Wang, Ruili Sun, Mingzhi Ling, Jingjing Zhai and 1 more

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Microorganisms · 2020
    Review
  10. Collectins: Innate Immune Pattern Recognition Molecules.Advances in experimental medicine and biology · 2020
    Review
  11. Article
  12. Observational
  13. Review
  14. Article
  15. C-type lectin receptors in tuberculosis: what we know.Medical microbiology and immunology · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mingyong WangDepartment of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
Fanping WangDepartment of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
Jianbin YangDepartment of Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Dongfang ZhaoDepartment of Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Hongpo WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Feng ShaoDepartment of Clinical Laboratory, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Wenjun WangCancer Research Institute, Southern Medical University, Guangzhou, China.
Ruili SunDepartment of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
Mingzhi LingDepartment of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
Jingjing ZhaiDepartment of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
Shijun SongDepartment of Clinical Laboratory, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCandida albicans (C. albicans), the most common human fungal pathogen, can cause fatal systemic infections under certain circumstances. Mannan-binding lectin (MBL),a member of the collectin family in the C-type lectin superfamily, is an important serum component associated with innate immunity. Toll-like receptors (TLRs) are expressed extensively, and have been shown to be involved in C. albicans-induced cellular responses. We first examined whether MBL modulated heat-killed (HK) C. albicans-induced cellular responses in phorbol 12-myristate 13-acetate (PMA)-activated human THP-1 macrophages. We then investigated the possible mechanisms of its inhibitory effect. METHODOLOGY/PRINCIPAL FINDING: Enzyme-linked immunosorbent assay (ELISA) and reverse transcriptasepolymerase chain reaction (RT-PCR) analysis showed that MBL at higher concentrations (10-20 µg/ml) significantly attenuated C. albicans-induced chemokine (e.g., IL-8) and proinflammatory cytokine (e.g., TNF-α) production from PMA-activated THP-1 cells at both protein and mRNA levels. Electrophoretic mobility shift assay (EMSA) and Western blot (WB) analysis showed that MBL could inhibit C. albicans-induced nuclear factor-κB (NF-κB) DNA binding and its translocation in PMA-activated THP-1 cells. MBL could directly bind to PMA-activated THP-1 cells in the presence of Ca(2+), and this binding decreased TLR2 and TLR4 expressions in C. albicans-induced THP-1 macrophages. Furthermore, the binding could be partially inhibited by both anti-TLR2 monoclonal antibody (clone TL2.1) and anti-TLR4 monoclonal antibody (clone HTA125). In addition, co-immunoprecipitation experiments and microtiter wells assay showed that MBL could directly bind to the recombinant soluble form of extracellular TLR2 domain (sTLR2) and sTLR4. CONCLUSIONS/SIGNIFICANCE: Our study demonstrates that MBL can affect proinflammatory cytokine and chemokine expressions by modifying C. albicans-/TLR-signaling pathways. This study supports an important role for MBL on the regulation of C. albicans-induced cellular responses.

Indexed as

Candida albicansCell LineDNAGene ExpressionHumansImmunity, InnateInterleukin-8MacrophagesMannose-Binding LectinNF-kappa BProtein BindingRNA, MessengerTetradecanoylphorbol AcetateToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alphaCXCL8 protein, humanDNAInterleukin-8Mannose-Binding LectinNF-kappa BRNA, MessengerTetradecanoylphorbol AcetateTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID24391778
PMCPMC3877063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.